Ensign Peak Advisors’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$215K Sell
9,300
-285,450
-97% -$6.59M ﹤0.01% 1677
2025
Q1
$7.96M Buy
294,750
+152,450
+107% +$4.12M 0.02% 522
2024
Q4
$7.62M Buy
142,300
+9,300
+7% +$498K 0.01% 541
2024
Q3
$6.04M Hold
133,000
0.01% 569
2024
Q2
$5.57M Buy
+133,000
New +$5.57M 0.01% 595